Members can sign in here.

About the Author

Ana Silva
Student (Coimbra,Portugal)

Undergraduate student of International Relations, with special interest on gender studies, European Union, international organisations and theories of IR, among other things. I will focus essentially on MDGs, as I consider these to be a very important "feature" that embodies the most important premises of the international system at the present time. They are probably going to fail, but even so we ought to call for the conscience of everybody, so that people become aware of what is being done by their national governments concerning the problems that ultimately affect each and every one of us.


Target 8.E: Access to medicinal drugs

Published 25th July 2010 - 1 comments - 1393 views -

I. Principles of action:

“In cooperation with pharmaceutical companies, provide access to affordable essential drugs in developing countries.”

II. Criticisms:

Samir Amin also charges on developed countries for what he considers to be a contradiction in terms present in this target’s premise. From his point of view, the “generous intention to provide access to drugs” necessarily collides with the referred cooperation with pharmaceutical companies, those that exerce the monopoly of medicines, making it so difficult for some developing countries’ inhabitants to afford some basic drugs that could prevent simple diseases which, nevertheless, still kill millions of people every year.

III. Progress:

The situation concerning this target is not particularly encouraging, and the fact that the average price of essential medicines in developing countries is still 2.5 times higher than the reference international prices in the public sector, and 6.1 in the private sector, leads us to tend to the same line of thought of Samir Amin, who criticizes the action of big pharmaceutical companies that own the intellectual property rights, as well as the position of political leaders that align with them instead of trying to combat their nocive practices. It is known that engagements in this matter are not usually settled to specific targets, which once again makes it difficult to properly assess whether we are on track to meet the deadline or not . Furthermore, the most recent UN data reckon an increasement in the number of people who have no access to essential medecines, again due to the effects of global economic crisis, even though some countries’ past exemples show that crisis time can instead be a turning point used to introduce the needed political and social changes that will allow improvements concerning health conditions and access to medicines. In addition, even if non-transmittable diseases (such as cardiovascular diseades) are responsible for most of the deaths occurring in developing countries, the attention of international actors is mainly focused on diseades such as HIV/Aids or tuberculosis, whose prevention and reduction are actually the subject of MDG 6 – ”Combating HIV/Aids, malaria and other diseases”.

Category: Aid | Tags:


  • Benno Hansen on 26th July 2010:

    The poor have to die watching the rich live on until the research investment has been returned. It’s either this - some dead now, many saved later - or no investment in research and no-one saved at all, everyone dies. In the mean time buy stocks in Gilead Sciences. Donald Rumsfeld did.

Post your comment

  • Remember my personal information

    Notify me of follow-up comments?

    --- Let's see if you are human ---

    What is the fourth word of this sentence? Add a questionmark to your answer. (7 character(s) required)